Sort Results:

List of Materials

  • 1
  • .....
  • 3
 
 
PPT
Academic Drug Discovery in the Center for Integrative Chemical Biology and Drug Discovery

Learn more about the Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina Chapel Hill . This presentation discusses the Center's vision, mission, capabilities, process and portfolio and highlights.

 

Center for Integrative Chemical Biology and Drug Discovery

 

University of North Carolina Chapel Hill

 

Presenter: Stephen V. Frye, Ph.D.

PPT
Academics in CNS Therapy Discovery

The business of drug discovery is changing. Pharma has historically played the principal role in small molecule drug development, and academia has traditionally conducted the basic research studies, providing pharma with the molecular targets to purs...

 

Brain Science Institute NeuroTranslational Drug Discovery Program

 

Johns Hopkins University

 

Presenter: Barbara Slusher, Ph.D., M.A.S.

PPT
Alternative Approaches To Lead Generation

Historically, drug discovery was chiefly an empirical enterprise, with the shift to a more hypothesis-driven approach occurring in the 20th century. Whereas originally drug discovery was focused primarily on identifying therapeutically useful agents...

 

 

University of Kansas Medical Center

 

Presenter: S.J. Enna, Ph.D.

Document
Big data in drug safety

Safety and efficacy information on drugs shall be communicated to all stakeholders, including physicians, patients, insurers and investors, in a format that allows objective assessment of real value of the intervention compared to other treatments. B...

 

 

ARETE-ZOE, LLC

 

Presenter: Veronika Valdova

PPT
Biopharmaceutical Development and QA/QC

This collection of biopharmaceutical applications will help you find the right solution for your analytical needs.

 

 

Agilent Technologies

 

Presenter: Agilent Technologies

PPT
Changing Landscape of Drug Discovery in Industry Settings

This lecture entitled “Changing Landscape of Drug Discovery in Industry Settings” introduces the drug discovery and development process to a class focused on a range of topics related to discovery and development of new therapeutic agents and dev...

 

Vanderbilt Center for Neuroscience Drug Discovery

 

Vanderbilt University

 

Presenter: P. Jeffrey Conn

PPT
Compliance for Biopharmaceutical Laboratories

This primer is intended to introduce FDA and equivalent international requirements. The primer will also give strategies and specific recommendations for regulated laboratories on how to implement the requirements in the most cost effective way.

 

 

Agilent Technologies

 

Presenter: Agilent Technologies

PPT
Drug Discovery and the Biopharmaceutical Ecosystem: The Imperative for New R&D Models “The Evolving Role of Academic Drug Discovery”

This presentation by Dr. Steven Paul was the keynote address for the "Johns Hopkins Brain Science Institute's Drug Discovery in Academia: The new paradigm in drug discovery" conference.

 

 

Weill Cornell Medical College of Cornell University

 

Presenter: Steven M. Paul, M.D.

PPT
First-In-Man - risk assessment

The example of TeGenero first-in-man case study was used to explore the usability of systems theoretic accident modeling and processes (STAMP) to create control structure of selected critical points in drug development, approval and commercialization...

 

 

ARETE-ZOE, LLC

 

Presenter: Veronika Valdova

PPT
Funding Academic Drug Discovery

The NIH supports drug discovery and development for nervous system disorders through a variety of programs. Some provide funding through grants or cooperative agreements to support specific stages of research and development, for particular disease a...

 

 

NINDS Office of Translational Research

 

Presenter: Rebecca Farkas, Ph.D.

  • 1
  • .....
  • 3